SunOpta STKL NASDAQ · Consumer defensive · United States
$6.50 +0.15% +$0.01
Summary
16 / 100 · Bulios Score
What speaks for it
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- Revenue fell by 7.4% a year over the last 3 years.
- You pay 50.8 USD for 1 USD of yearly profit, a lot for its sector.
- Operating profit covers the interest on its debt only 1.7 times.
- Out of every 100 USD of revenue, only 1.9 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedToday you pay 50.8 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
- Analyst estimate
Revenue grew by 0.7% a year over 5 years. Over the last 3 years it fell by 7.4% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 4
- Sell 0
No analyst has published a price target.
80% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.